nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Vinblastine—head and neck cancer	0.183	0.221	CbGbCtD
Mifepristone—ABCC1—Docetaxel—head and neck cancer	0.151	0.182	CbGbCtD
Mifepristone—CYP2D6—Hydroxyurea—head and neck cancer	0.117	0.142	CbGbCtD
Mifepristone—CYP3A7—Docetaxel—head and neck cancer	0.0744	0.0902	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0744	0.0902	CbGbCtD
Mifepristone—CYP3A5—Docetaxel—head and neck cancer	0.0558	0.0676	CbGbCtD
Mifepristone—ABCB1—Vinblastine—head and neck cancer	0.0441	0.0534	CbGbCtD
Mifepristone—CYP2D6—Vinblastine—head and neck cancer	0.0415	0.0503	CbGbCtD
Mifepristone—ABCB1—Docetaxel—head and neck cancer	0.0363	0.044	CbGbCtD
Mifepristone—CYP3A4—Vinblastine—head and neck cancer	0.0264	0.032	CbGbCtD
Mifepristone—CYP3A4—Docetaxel—head and neck cancer	0.0218	0.0264	CbGbCtD
Mifepristone—AR—duct of salivary gland—head and neck cancer	0.0208	0.516	CbGeAlD
Mifepristone—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00189	0.0229	CcSEcCtD
Mifepristone—ABCC1—hair follicle—head and neck cancer	0.00167	0.0416	CbGeAlD
Mifepristone—Breast disorder—Hydroxyurea—head and neck cancer	0.00136	0.0165	CcSEcCtD
Mifepristone—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00136	0.0164	CcSEcCtD
Mifepristone—Infestation NOS—Hydroxyurea—head and neck cancer	0.00116	0.0141	CcSEcCtD
Mifepristone—Infestation—Hydroxyurea—head and neck cancer	0.00116	0.0141	CcSEcCtD
Mifepristone—Haemoglobin—Vinblastine—head and neck cancer	0.00115	0.0139	CcSEcCtD
Mifepristone—Haemorrhage—Vinblastine—head and neck cancer	0.00114	0.0138	CcSEcCtD
Mifepristone—PGR—connective tissue—head and neck cancer	0.00106	0.0264	CbGeAlD
Mifepristone—Haemoglobin—Hydroxyurea—head and neck cancer	0.00105	0.0127	CcSEcCtD
Mifepristone—Haemorrhage—Hydroxyurea—head and neck cancer	0.00104	0.0126	CcSEcCtD
Mifepristone—PGR—epithelium—head and neck cancer	0.00101	0.0251	CbGeAlD
Mifepristone—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000971	0.0117	CcSEcCtD
Mifepristone—Muscular weakness—Fluorouracil—head and neck cancer	0.000958	0.0116	CcSEcCtD
Mifepristone—Angiopathy—Hydroxyurea—head and neck cancer	0.000947	0.0115	CcSEcCtD
Mifepristone—Chills—Hydroxyurea—head and neck cancer	0.000936	0.0113	CcSEcCtD
Mifepristone—Ill-defined disorder—Vinblastine—head and neck cancer	0.000924	0.0112	CcSEcCtD
Mifepristone—ABCC1—parotid gland—head and neck cancer	0.000914	0.0227	CbGeAlD
Mifepristone—Malaise—Vinblastine—head and neck cancer	0.000898	0.0109	CcSEcCtD
Mifepristone—Hypertension—Vinblastine—head and neck cancer	0.00086	0.0104	CcSEcCtD
Mifepristone—NR3C1—neck—head and neck cancer	0.000856	0.0213	CbGeAlD
Mifepristone—AR—connective tissue—head and neck cancer	0.000847	0.021	CbGeAlD
Mifepristone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000843	0.0102	CcSEcCtD
Mifepristone—Discomfort—Vinblastine—head and neck cancer	0.000838	0.0101	CcSEcCtD
Mifepristone—Hot flush—Docetaxel—head and neck cancer	0.000838	0.0101	CcSEcCtD
Mifepristone—Infestation NOS—Fluorouracil—head and neck cancer	0.000837	0.0101	CcSEcCtD
Mifepristone—Infestation—Fluorouracil—head and neck cancer	0.000837	0.0101	CcSEcCtD
Mifepristone—Menopausal symptoms—Docetaxel—head and neck cancer	0.00083	0.01	CcSEcCtD
Mifepristone—Malaise—Hydroxyurea—head and neck cancer	0.000819	0.00991	CcSEcCtD
Mifepristone—AR—epithelium—head and neck cancer	0.000804	0.02	CbGeAlD
Mifepristone—Sinusitis—Fluorouracil—head and neck cancer	0.000785	0.0095	CcSEcCtD
Mifepristone—Pain in extremity—Docetaxel—head and neck cancer	0.000784	0.00948	CcSEcCtD
Mifepristone—PGR—lymphoid tissue—head and neck cancer	0.000777	0.0193	CbGeAlD
Mifepristone—Anorexia—Vinblastine—head and neck cancer	0.000775	0.00938	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000768	0.00929	CcSEcCtD
Mifepristone—Discomfort—Hydroxyurea—head and neck cancer	0.000764	0.00924	CcSEcCtD
Mifepristone—Haemoglobin—Fluorouracil—head and neck cancer	0.000755	0.00913	CcSEcCtD
Mifepristone—Haemorrhage—Fluorouracil—head and neck cancer	0.000751	0.00909	CcSEcCtD
Mifepristone—Oedema—Hydroxyurea—head and neck cancer	0.000741	0.00897	CcSEcCtD
Mifepristone—Infection—Hydroxyurea—head and neck cancer	0.000736	0.00891	CcSEcCtD
Mifepristone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000727	0.0088	CcSEcCtD
Mifepristone—Skin disorder—Hydroxyurea—head and neck cancer	0.00072	0.00871	CcSEcCtD
Mifepristone—Breast disorder—Docetaxel—head and neck cancer	0.000708	0.00857	CcSEcCtD
Mifepristone—Anorexia—Hydroxyurea—head and neck cancer	0.000707	0.00855	CcSEcCtD
Mifepristone—Decreased appetite—Vinblastine—head and neck cancer	0.000707	0.00855	CcSEcCtD
Mifepristone—PGR—thyroid gland—head and neck cancer	0.000706	0.0175	CbGeAlD
Mifepristone—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000706	0.00854	CcSEcCtD
Mifepristone—Cramp muscle—Docetaxel—head and neck cancer	0.000706	0.00854	CcSEcCtD
Mifepristone—Nasopharyngitis—Docetaxel—head and neck cancer	0.000701	0.00848	CcSEcCtD
Mifepristone—NR3C1—parotid gland—head and neck cancer	0.000697	0.0173	CbGeAlD
Mifepristone—Constipation—Vinblastine—head and neck cancer	0.000695	0.00841	CcSEcCtD
Mifepristone—Pain—Vinblastine—head and neck cancer	0.000695	0.00841	CcSEcCtD
Mifepristone—ABCC1—trachea—head and neck cancer	0.000675	0.0168	CbGeAlD
Mifepristone—Feeling abnormal—Vinblastine—head and neck cancer	0.00067	0.0081	CcSEcCtD
Mifepristone—NR3C1—saliva-secreting gland—head and neck cancer	0.000668	0.0166	CbGeAlD
Mifepristone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000665	0.00804	CcSEcCtD
Mifepristone—Dyspnoea—Hydroxyurea—head and neck cancer	0.000661	0.008	CcSEcCtD
Mifepristone—Somnolence—Hydroxyurea—head and neck cancer	0.000659	0.00797	CcSEcCtD
Mifepristone—Decreased appetite—Hydroxyurea—head and neck cancer	0.000644	0.0078	CcSEcCtD
Mifepristone—Abdominal pain—Vinblastine—head and neck cancer	0.000643	0.00777	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00064	0.00774	CcSEcCtD
Mifepristone—Fatigue—Hydroxyurea—head and neck cancer	0.000639	0.00773	CcSEcCtD
Mifepristone—Constipation—Hydroxyurea—head and neck cancer	0.000634	0.00767	CcSEcCtD
Mifepristone—Pain—Hydroxyurea—head and neck cancer	0.000634	0.00767	CcSEcCtD
Mifepristone—PGR—head—head and neck cancer	0.000626	0.0156	CbGeAlD
Mifepristone—AR—lymphoid tissue—head and neck cancer	0.000619	0.0154	CbGeAlD
Mifepristone—NR3C1—connective tissue—head and neck cancer	0.000614	0.0152	CbGeAlD
Mifepristone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000611	0.00739	CcSEcCtD
Mifepristone—Infestation—Docetaxel—head and neck cancer	0.000604	0.00731	CcSEcCtD
Mifepristone—Infestation NOS—Docetaxel—head and neck cancer	0.000604	0.00731	CcSEcCtD
Mifepristone—Hypersensitivity—Vinblastine—head and neck cancer	0.000599	0.00725	CcSEcCtD
Mifepristone—Body temperature increased—Hydroxyurea—head and neck cancer	0.000586	0.00709	CcSEcCtD
Mifepristone—Asthenia—Vinblastine—head and neck cancer	0.000583	0.00706	CcSEcCtD
Mifepristone—NR3C1—epithelium—head and neck cancer	0.000582	0.0145	CbGeAlD
Mifepristone—AR—thyroid gland—head and neck cancer	0.000563	0.014	CbGeAlD
Mifepristone—Myalgia—Fluorouracil—head and neck cancer	0.000557	0.00673	CcSEcCtD
Mifepristone—Diarrhoea—Vinblastine—head and neck cancer	0.000556	0.00673	CcSEcCtD
Mifepristone—Discomfort—Fluorouracil—head and neck cancer	0.00055	0.00665	CcSEcCtD
Mifepristone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000546	0.00661	CcSEcCtD
Mifepristone—Haemoglobin—Docetaxel—head and neck cancer	0.000545	0.00659	CcSEcCtD
Mifepristone—Haemorrhage—Docetaxel—head and neck cancer	0.000542	0.00656	CcSEcCtD
Mifepristone—Dizziness—Vinblastine—head and neck cancer	0.000538	0.0065	CcSEcCtD
Mifepristone—ABCC1—thyroid gland—head and neck cancer	0.000534	0.0133	CbGeAlD
Mifepristone—Oedema peripheral—Docetaxel—head and neck cancer	0.000534	0.00646	CcSEcCtD
Mifepristone—Oedema—Fluorouracil—head and neck cancer	0.000534	0.00646	CcSEcCtD
Mifepristone—Connective tissue disorder—Docetaxel—head and neck cancer	0.000533	0.00645	CcSEcCtD
Mifepristone—Asthenia—Hydroxyurea—head and neck cancer	0.000532	0.00644	CcSEcCtD
Mifepristone—Infection—Fluorouracil—head and neck cancer	0.00053	0.00641	CcSEcCtD
Mifepristone—Nervous system disorder—Fluorouracil—head and neck cancer	0.000523	0.00633	CcSEcCtD
Mifepristone—Vomiting—Vinblastine—head and neck cancer	0.000517	0.00625	CcSEcCtD
Mifepristone—NR3C1—trachea—head and neck cancer	0.000515	0.0128	CbGeAlD
Mifepristone—Headache—Vinblastine—head and neck cancer	0.000509	0.00616	CcSEcCtD
Mifepristone—Anorexia—Fluorouracil—head and neck cancer	0.000509	0.00615	CcSEcCtD
Mifepristone—Diarrhoea—Hydroxyurea—head and neck cancer	0.000507	0.00614	CcSEcCtD
Mifepristone—AR—head—head and neck cancer	0.000499	0.0124	CbGeAlD
Mifepristone—Hypotension—Fluorouracil—head and neck cancer	0.000499	0.00603	CcSEcCtD
Mifepristone—Angiopathy—Docetaxel—head and neck cancer	0.000492	0.00595	CcSEcCtD
Mifepristone—Dizziness—Hydroxyurea—head and neck cancer	0.00049	0.00593	CcSEcCtD
Mifepristone—Mediastinal disorder—Docetaxel—head and neck cancer	0.000489	0.00591	CcSEcCtD
Mifepristone—Chills—Docetaxel—head and neck cancer	0.000486	0.00589	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000486	0.00588	CcSEcCtD
Mifepristone—Nausea—Vinblastine—head and neck cancer	0.000483	0.00584	CcSEcCtD
Mifepristone—Insomnia—Fluorouracil—head and neck cancer	0.000483	0.00584	CcSEcCtD
Mifepristone—Dyspnoea—Fluorouracil—head and neck cancer	0.000476	0.00576	CcSEcCtD
Mifepristone—Mental disorder—Docetaxel—head and neck cancer	0.000475	0.00575	CcSEcCtD
Mifepristone—Somnolence—Fluorouracil—head and neck cancer	0.000474	0.00574	CcSEcCtD
Mifepristone—Malnutrition—Docetaxel—head and neck cancer	0.000472	0.00571	CcSEcCtD
Mifepristone—Vomiting—Hydroxyurea—head and neck cancer	0.000471	0.0057	CcSEcCtD
Mifepristone—Rash—Hydroxyurea—head and neck cancer	0.000467	0.00566	CcSEcCtD
Mifepristone—Dermatitis—Hydroxyurea—head and neck cancer	0.000467	0.00565	CcSEcCtD
Mifepristone—Headache—Hydroxyurea—head and neck cancer	0.000464	0.00562	CcSEcCtD
Mifepristone—Decreased appetite—Fluorouracil—head and neck cancer	0.000464	0.00561	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000461	0.00557	CcSEcCtD
Mifepristone—Back pain—Docetaxel—head and neck cancer	0.000456	0.00552	CcSEcCtD
Mifepristone—Pain—Fluorouracil—head and neck cancer	0.000456	0.00552	CcSEcCtD
Mifepristone—Muscle spasms—Docetaxel—head and neck cancer	0.000454	0.00549	CcSEcCtD
Mifepristone—NR3C1—lymphoid tissue—head and neck cancer	0.000449	0.0111	CbGeAlD
Mifepristone—Nausea—Hydroxyurea—head and neck cancer	0.00044	0.00533	CcSEcCtD
Mifepristone—Feeling abnormal—Fluorouracil—head and neck cancer	0.00044	0.00532	CcSEcCtD
Mifepristone—PGR—lymph node—head and neck cancer	0.000439	0.0109	CbGeAlD
Mifepristone—Urticaria—Fluorouracil—head and neck cancer	0.000424	0.00513	CcSEcCtD
Mifepristone—Body temperature increased—Fluorouracil—head and neck cancer	0.000422	0.0051	CcSEcCtD
Mifepristone—NR3C1—thyroid gland—head and neck cancer	0.000407	0.0101	CbGeAlD
Mifepristone—Hypertension—Docetaxel—head and neck cancer	0.000407	0.00493	CcSEcCtD
Mifepristone—Arthralgia—Docetaxel—head and neck cancer	0.000402	0.00486	CcSEcCtD
Mifepristone—Myalgia—Docetaxel—head and neck cancer	0.000402	0.00486	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000399	0.00483	CcSEcCtD
Mifepristone—Hypersensitivity—Fluorouracil—head and neck cancer	0.000393	0.00476	CcSEcCtD
Mifepristone—Dry mouth—Docetaxel—head and neck cancer	0.000393	0.00475	CcSEcCtD
Mifepristone—Oedema—Docetaxel—head and neck cancer	0.000385	0.00466	CcSEcCtD
Mifepristone—Infection—Docetaxel—head and neck cancer	0.000383	0.00463	CcSEcCtD
Mifepristone—Nervous system disorder—Docetaxel—head and neck cancer	0.000378	0.00457	CcSEcCtD
Mifepristone—Pruritus—Fluorouracil—head and neck cancer	0.000378	0.00457	CcSEcCtD
Mifepristone—Skin disorder—Docetaxel—head and neck cancer	0.000374	0.00453	CcSEcCtD
Mifepristone—Anorexia—Docetaxel—head and neck cancer	0.000367	0.00444	CcSEcCtD
Mifepristone—Diarrhoea—Fluorouracil—head and neck cancer	0.000365	0.00442	CcSEcCtD
Mifepristone—NR3C1—head—head and neck cancer	0.000361	0.00898	CbGeAlD
Mifepristone—Hypotension—Docetaxel—head and neck cancer	0.00036	0.00435	CcSEcCtD
Mifepristone—Dizziness—Fluorouracil—head and neck cancer	0.000353	0.00427	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000351	0.00425	CcSEcCtD
Mifepristone—AR—lymph node—head and neck cancer	0.000349	0.00868	CbGeAlD
Mifepristone—Insomnia—Docetaxel—head and neck cancer	0.000348	0.00421	CcSEcCtD
Mifepristone—Dyspnoea—Docetaxel—head and neck cancer	0.000343	0.00415	CcSEcCtD
Mifepristone—Somnolence—Docetaxel—head and neck cancer	0.000342	0.00414	CcSEcCtD
Mifepristone—Vomiting—Fluorouracil—head and neck cancer	0.000339	0.0041	CcSEcCtD
Mifepristone—Rash—Fluorouracil—head and neck cancer	0.000336	0.00407	CcSEcCtD
Mifepristone—Dermatitis—Fluorouracil—head and neck cancer	0.000336	0.00407	CcSEcCtD
Mifepristone—Decreased appetite—Docetaxel—head and neck cancer	0.000335	0.00405	CcSEcCtD
Mifepristone—Headache—Fluorouracil—head and neck cancer	0.000334	0.00404	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000332	0.00402	CcSEcCtD
Mifepristone—Fatigue—Docetaxel—head and neck cancer	0.000332	0.00402	CcSEcCtD
Mifepristone—ABCC1—lymph node—head and neck cancer	0.000332	0.00824	CbGeAlD
Mifepristone—Constipation—Docetaxel—head and neck cancer	0.000329	0.00398	CcSEcCtD
Mifepristone—Pain—Docetaxel—head and neck cancer	0.000329	0.00398	CcSEcCtD
Mifepristone—CYP3A7—Metapathway biotransformation—NAT2—head and neck cancer	0.000317	0.0061	CbGpPWpGaD
Mifepristone—Feeling abnormal—Docetaxel—head and neck cancer	0.000317	0.00384	CcSEcCtD
Mifepristone—Nausea—Fluorouracil—head and neck cancer	0.000317	0.00383	CcSEcCtD
Mifepristone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000315	0.00381	CcSEcCtD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.000314	0.00603	CbGpPWpGaD
Mifepristone—ABCB1—epithelium—head and neck cancer	0.000312	0.00774	CbGeAlD
Mifepristone—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000308	0.00592	CbGpPWpGaD
Mifepristone—Abdominal pain—Docetaxel—head and neck cancer	0.000304	0.00368	CcSEcCtD
Mifepristone—Body temperature increased—Docetaxel—head and neck cancer	0.000304	0.00368	CcSEcCtD
Mifepristone—AR—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.000291	0.00558	CbGpPWpGaD
Mifepristone—Hypersensitivity—Docetaxel—head and neck cancer	0.000284	0.00343	CcSEcCtD
Mifepristone—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000284	0.00545	CbGpPWpGaD
Mifepristone—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000283	0.00544	CbGpPWpGaD
Mifepristone—Asthenia—Docetaxel—head and neck cancer	0.000276	0.00334	CcSEcCtD
Mifepristone—ABCC1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000276	0.0053	CbGpPWpGaD
Mifepristone—ABCB1—trachea—head and neck cancer	0.000276	0.00685	CbGeAlD
Mifepristone—Pruritus—Docetaxel—head and neck cancer	0.000272	0.0033	CcSEcCtD
Mifepristone—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000272	0.00523	CbGpPWpGaD
Mifepristone—CYP2D6—head—head and neck cancer	0.000269	0.00668	CbGeAlD
Mifepristone—AR—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.000269	0.00517	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—head and neck cancer	0.000268	0.00515	CbGpPWpGaD
Mifepristone—AR—Notch-mediated HES/HEY network—STAT3—head and neck cancer	0.000264	0.00507	CbGpPWpGaD
Mifepristone—Diarrhoea—Docetaxel—head and neck cancer	0.000264	0.00319	CcSEcCtD
Mifepristone—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.000257	0.00495	CbGpPWpGaD
Mifepristone—Dizziness—Docetaxel—head and neck cancer	0.000255	0.00308	CcSEcCtD
Mifepristone—NR3C1—lymph node—head and neck cancer	0.000253	0.00629	CbGeAlD
Mifepristone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000253	0.00486	CbGpPWpGaD
Mifepristone—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00025	0.0048	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—CCND1—head and neck cancer	0.000248	0.00477	CbGpPWpGaD
Mifepristone—Vomiting—Docetaxel—head and neck cancer	0.000245	0.00296	CcSEcCtD
Mifepristone—Rash—Docetaxel—head and neck cancer	0.000243	0.00294	CcSEcCtD
Mifepristone—Dermatitis—Docetaxel—head and neck cancer	0.000243	0.00294	CcSEcCtD
Mifepristone—Headache—Docetaxel—head and neck cancer	0.000241	0.00292	CcSEcCtD
Mifepristone—ABCB1—lymphoid tissue—head and neck cancer	0.00024	0.00596	CbGeAlD
Mifepristone—AR—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.000237	0.00456	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—RARB—head and neck cancer	0.000236	0.00454	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000233	0.00447	CbGpPWpGaD
Mifepristone—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000229	0.00441	CbGpPWpGaD
Mifepristone—Nausea—Docetaxel—head and neck cancer	0.000229	0.00277	CcSEcCtD
Mifepristone—ABCB1—thyroid gland—head and neck cancer	0.000218	0.00542	CbGeAlD
Mifepristone—PGR—Generic Transcription Pathway—YAP1—head and neck cancer	0.000215	0.00413	CbGpPWpGaD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000205	0.00394	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—head and neck cancer	0.0002	0.00384	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000198	0.0038	CbGpPWpGaD
Mifepristone—ABCB1—head—head and neck cancer	0.000194	0.00481	CbGeAlD
Mifepristone—AR—Androgen receptor signaling pathway—CCND1—head and neck cancer	0.000184	0.00353	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—RARB—head and neck cancer	0.00018	0.00346	CbGpPWpGaD
Mifepristone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00018	0.00346	CbGpPWpGaD
Mifepristone—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000177	0.00341	CbGpPWpGaD
Mifepristone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	0.000177	0.00341	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—PTEN—head and neck cancer	0.000177	0.0034	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.000173	0.00333	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00017	0.00328	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000169	0.00324	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000165	0.00318	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—YAP1—head and neck cancer	0.000164	0.00315	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000163	0.00314	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000163	0.00314	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000163	0.00313	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000161	0.0031	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000159	0.00305	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—STAT3—head and neck cancer	0.000158	0.00304	CbGpPWpGaD
Mifepristone—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000157	0.00301	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.000153	0.00293	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—UROD—head and neck cancer	0.000152	0.00292	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—PTEN—head and neck cancer	0.000152	0.00291	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.000151	0.0029	CbGpPWpGaD
Mifepristone—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000149	0.00286	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000148	0.00284	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000146	0.0028	CbGpPWpGaD
Mifepristone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000145	0.0028	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—EGFR—head and neck cancer	0.000144	0.00277	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.00014	0.00269	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—AKT1—head and neck cancer	0.000138	0.00265	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.000137	0.00262	CbGpPWpGaD
Mifepristone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000136	0.00262	CbGpPWpGaD
Mifepristone—ABCB1—lymph node—head and neck cancer	0.000136	0.00337	CbGeAlD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000135	0.0026	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000134	0.00258	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—UROD—head and neck cancer	0.000133	0.00255	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—MAPK3—head and neck cancer	0.000129	0.00249	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000124	0.00239	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—MAPK1—head and neck cancer	0.000123	0.00237	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—EGFR—head and neck cancer	0.000123	0.00237	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000123	0.00236	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.00012	0.00231	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000118	0.00227	CbGpPWpGaD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000118	0.00226	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.000117	0.00224	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000116	0.00223	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000116	0.00223	CbGpPWpGaD
Mifepristone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000116	0.00223	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000115	0.00221	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—RARB—head and neck cancer	0.000114	0.00219	CbGpPWpGaD
Mifepristone—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000113	0.00218	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000112	0.00215	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000111	0.00214	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00011	0.00212	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.00011	0.00212	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000109	0.00209	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000108	0.00208	CbGpPWpGaD
Mifepristone—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000107	0.00206	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000107	0.00205	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000107	0.00205	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000105	0.00201	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—YAP1—head and neck cancer	0.000103	0.00199	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000102	0.00196	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—AKT1—head and neck cancer	0.000102	0.00196	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	9.96e-05	0.00191	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—HRAS—head and neck cancer	9.89e-05	0.0019	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	9.79e-05	0.00188	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—NOTCH1—head and neck cancer	9.68e-05	0.00186	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	9.62e-05	0.00185	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—UROD—head and neck cancer	9.58e-05	0.00184	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.53e-05	0.00183	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KISS1—head and neck cancer	9.51e-05	0.00183	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	9.44e-05	0.00181	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	9.43e-05	0.00181	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—STAT3—head and neck cancer	8.88e-05	0.00171	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—AKT1—head and neck cancer	8.73e-05	0.00168	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	8.69e-05	0.00167	CbGpPWpGaD
Mifepristone—AR—Gene Expression—RARB—head and neck cancer	8.66e-05	0.00166	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL2—head and neck cancer	8.44e-05	0.00162	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	8.35e-05	0.00161	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	8.28e-05	0.00159	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	8.27e-05	0.00159	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	8.22e-05	0.00158	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	8.17e-05	0.00157	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	8.11e-05	0.00156	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	8.07e-05	0.00155	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	8.06e-05	0.00155	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	7.92e-05	0.00152	CbGpPWpGaD
Mifepristone—AR—Gene Expression—YAP1—head and neck cancer	7.88e-05	0.00151	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GRP—head and neck cancer	7.83e-05	0.0015	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	7.82e-05	0.0015	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	7.82e-05	0.0015	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	7.75e-05	0.00149	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	7.75e-05	0.00149	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	7.64e-05	0.00147	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT6—head and neck cancer	7.6e-05	0.00146	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—NOTCH1—head and neck cancer	7.38e-05	0.00142	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—UROD—head and neck cancer	7.23e-05	0.00139	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	7.17e-05	0.00138	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—UROD—head and neck cancer	6.81e-05	0.00131	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	6.78e-05	0.0013	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—YAP1—head and neck cancer	6.73e-05	0.00129	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.7e-05	0.00129	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	6.69e-05	0.00129	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.63e-05	0.00127	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RARB—head and neck cancer	6.57e-05	0.00126	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	6.56e-05	0.00126	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NAT2—head and neck cancer	6.31e-05	0.00121	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—YAP1—head and neck cancer	5.98e-05	0.00115	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	5.6e-05	0.00108	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.54e-05	0.00107	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—DPYD—head and neck cancer	5.53e-05	0.00106	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	5.51e-05	0.00106	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NAT2—head and neck cancer	5.5e-05	0.00106	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.34e-05	0.00103	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	5.29e-05	0.00102	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.27e-05	0.00101	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—YAP1—head and neck cancer	5.25e-05	0.00101	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	5.06e-05	0.000973	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.99e-05	0.00096	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—DPYD—head and neck cancer	4.83e-05	0.000927	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.73e-05	0.000909	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NOTCH1—head and neck cancer	4.66e-05	0.000896	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—YAP1—head and neck cancer	4.58e-05	0.00088	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	4.49e-05	0.000864	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—UROD—head and neck cancer	4.45e-05	0.000856	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	4.06e-05	0.00078	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NAT2—head and neck cancer	3.98e-05	0.000765	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.95e-05	0.000758	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.92e-05	0.000753	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NOTCH1—head and neck cancer	3.55e-05	0.000683	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.54e-05	0.00068	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—DPYD—head and neck cancer	3.49e-05	0.00067	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.44e-05	0.000661	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.35e-05	0.000644	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—YAP1—head and neck cancer	3.31e-05	0.000636	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.19e-05	0.000612	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.19e-05	0.000612	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TYMS—head and neck cancer	3.15e-05	0.000606	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTM1—head and neck cancer	3.12e-05	0.000599	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH1—head and neck cancer	3.03e-05	0.000583	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NAT2—head and neck cancer	3e-05	0.000577	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GPX1—head and neck cancer	2.98e-05	0.000574	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP1A1—head and neck cancer	2.95e-05	0.000568	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NAT2—head and neck cancer	2.83e-05	0.000544	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOTCH1—head and neck cancer	2.83e-05	0.000543	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.77e-05	0.000531	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TYMS—head and neck cancer	2.75e-05	0.000528	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTM1—head and neck cancer	2.72e-05	0.000522	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH1—head and neck cancer	2.7e-05	0.000518	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.68e-05	0.000514	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—DPYD—head and neck cancer	2.63e-05	0.000506	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GPX1—head and neck cancer	2.6e-05	0.0005	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MAPK3—head and neck cancer	2.58e-05	0.000496	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP1A1—head and neck cancer	2.58e-05	0.000495	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—YAP1—head and neck cancer	2.5e-05	0.00048	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—DPYD—head and neck cancer	2.48e-05	0.000477	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.43e-05	0.000466	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—YAP1—head and neck cancer	2.35e-05	0.000452	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.26e-05	0.000434	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—head and neck cancer	2.1e-05	0.000403	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—head and neck cancer	2.09e-05	0.000401	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—head and neck cancer	2.03e-05	0.000391	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TYMS—head and neck cancer	1.99e-05	0.000382	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MAPK3—head and neck cancer	1.97e-05	0.000378	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.96e-05	0.000378	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—head and neck cancer	1.96e-05	0.000377	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GPX1—head and neck cancer	1.88e-05	0.000362	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.86e-05	0.000358	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NAT2—head and neck cancer	1.85e-05	0.000355	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—head and neck cancer	1.83e-05	0.000352	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—head and neck cancer	1.77e-05	0.000341	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—head and neck cancer	1.76e-05	0.000338	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—head and neck cancer	1.76e-05	0.000337	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—head and neck cancer	1.74e-05	0.000334	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK3—head and neck cancer	1.68e-05	0.000322	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—head and neck cancer	1.64e-05	0.000314	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—DPYD—head and neck cancer	1.62e-05	0.000312	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK1—head and neck cancer	1.6e-05	0.000307	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—head and neck cancer	1.6e-05	0.000307	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK3—head and neck cancer	1.56e-05	0.0003	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—YAP1—head and neck cancer	1.54e-05	0.000296	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—head and neck cancer	1.53e-05	0.000294	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—head and neck cancer	1.53e-05	0.000294	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TYMS—head and neck cancer	1.5e-05	0.000288	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAPK3—head and neck cancer	1.49e-05	0.000287	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK1—head and neck cancer	1.49e-05	0.000286	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—head and neck cancer	1.49e-05	0.000286	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTM1—head and neck cancer	1.48e-05	0.000285	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GPX1—head and neck cancer	1.42e-05	0.000273	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TYMS—head and neck cancer	1.41e-05	0.000272	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.41e-05	0.00027	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.4e-05	0.000269	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—head and neck cancer	1.38e-05	0.000266	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—head and neck cancer	1.34e-05	0.000257	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GPX1—head and neck cancer	1.34e-05	0.000257	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—head and neck cancer	1.34e-05	0.000257	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—head and neck cancer	1.33e-05	0.000255	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.32e-05	0.000255	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—head and neck cancer	1.29e-05	0.000248	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—head and neck cancer	1.28e-05	0.000246	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—head and neck cancer	1.19e-05	0.000229	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—head and neck cancer	1.13e-05	0.000217	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.11e-05	0.000213	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—head and neck cancer	1.08e-05	0.000208	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—head and neck cancer	1.05e-05	0.000203	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—head and neck cancer	1.01e-05	0.000193	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—head and neck cancer	9.66e-06	0.000186	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—head and neck cancer	9.43e-06	0.000181	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TYMS—head and neck cancer	9.24e-06	0.000178	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM1—head and neck cancer	9.13e-06	0.000176	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—head and neck cancer	8.83e-06	0.00017	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GPX1—head and neck cancer	8.75e-06	0.000168	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	8.66e-06	0.000166	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—head and neck cancer	8.36e-06	0.000161	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—head and neck cancer	7.88e-06	0.000151	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—head and neck cancer	7.7e-06	0.000148	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—head and neck cancer	7.29e-06	0.00014	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—head and neck cancer	6.87e-06	0.000132	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—head and neck cancer	6.82e-06	0.000131	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—head and neck cancer	5.57e-06	0.000107	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.15e-06	9.9e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—head and neck cancer	5.14e-06	9.88e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—head and neck cancer	4.85e-06	9.31e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—head and neck cancer	4.49e-06	8.63e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—head and neck cancer	4.2e-06	8.07e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—head and neck cancer	3.96e-06	7.61e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.17e-06	6.09e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—head and neck cancer	2.59e-06	4.97e-05	CbGpPWpGaD
